SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
488I bought some more today, on the theory that we are seeing window dressing here.tuck-6/30/2008
487"this looks like a bargain." And more like one every day. I have bitRocky9-6/30/2008
486I believe this is Zack's (I think that's where Napadano is employed) taktuck-6/27/2008
485Eur J Pharmacol. 2008 May 23. [Epub ahead of print] Broad modulation of neuropascaram(o)uche-6/21/2008
484citi: ACADIA Pharmaceuticals Inc (ACAD) Target prmopgcw-6/20/2008
483Looking into the failure a little more, I didn't realize this was one and thrkrw-6/18/2008
482Obesity (Silver Spring). 2008 Jun 12. [Epub ahead of print] The CB1 Endocannabiscaram(o)uche-6/16/2008
481Perhaps the Teva hit will stir the partnership interest in pimavanserin up. It&tuck-6/16/2008
480Interesting acadia fact: when 103 cotherapy with risperdal (I think) came out shrkrw-6/16/2008
479Teva is up *1.6B* or so in market cap today on their p3 hit for a PD drug. bizrkrw-6/16/2008
478That was in January 2007. I would have preferred to be wrong. Harry NeuroInvestNeuroInvestment-6/16/2008
477You guys are right this looks like a bargain. BTW, some time ago Dr. Tracy predkeokalani'nui-6/16/2008
476i agree. another slug swallowed at 4.60 i just got home and read the news, so cmopgcw-6/16/2008
475104 was the weakest looking aspect of the ACAD investment thesis. I have been stuck-6/16/2008
474ACADIA Pharmaceuticals Announces Results from ACP-104 Phase IIb Schizophrenia Trsim1-6/16/2008
473Acad's primavanserin is mention in this review: <b>Schizophrenia theridos-6/8/2008
472Pharmacol Biochem Behav. 2008 Apr 20. [Epub ahead of print] A 5-HT(2A) receptorscaram(o)uche-6/8/2008
471Behav Neurosci. 2008 Jun;122(3):570-5. Antipsychotic-like behavioral effects anscaram(o)uche-6/5/2008
470[Clozapine: more than 900 mg/day may be needed] >>J Psychopharmacol. 2008tuck-6/4/2008
469Biotech Wrap Up of Citi Healthcare Conference 22 May 2008 9 Citigroup Global Marmopgcw-5/23/2008
468citi: ACADIA Pharmaceuticals Inc (ACAD) 1Q08 Non-eventful Results - Waiting for mopgcw-5/14/2008
467Zacks.com Huge Upside for Biotech Acadia Tuesday May 6, 9:15 am ET By Jason Napmopgcw-5/6/2008
466Call transcript: seekingalpha.commopgcw-5/6/2008
465<i><b>CB1 antagonists induce rat chow-seeking behavior</b>....scaram(o)uche-5/5/2008
4649:03AM ACADIA Pharmaceuticals announces primary endpoint of Phase II trial with tnsaf-4/16/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News